Related Experiment Videos
[Problems of infection in drug addicts and current possibilities of treatment]
Abstract:
Cefuroxime (a third-generation cephalosporin) administered parenterally (mostly i.m.) at a dose of 2-4 g/day for 4-16 days (mean 9.26 days) displayed marked antibacterial activity and excellent tolerability when employed in the treatment of variously located acute infections in 120 drug addict out-patients with almost constant pronounced immune depression. The drug is regarded as the antibiotic of choice in the outpatient management of infection episodes in immunodepressed subjects at high risk of infection.
Insights
Cefuroxime demonstrated strong antibacterial effects and good tolerability in treating acute infections in 120 immunocompromised outpatients. This cephalosporin is recommended for outpatient infections in high-risk, immune-depressed individuals.
Area of Science:
- Infectious Diseases
- Pharmacology
- Immunology
Background:
- Bacterial infections pose significant risks, especially in immunocompromised individuals.
- Drug addicts often present with pronounced immune depression, increasing infection susceptibility.
- Effective outpatient antibiotic management is crucial for high-risk patient populations.
Purpose of the Study:
- To evaluate the efficacy and tolerability of cefuroxime in treating acute infections.
- To assess cefuroxime's suitability for outpatient management of infections in immune-depressed patients.
Main Methods:
- Parenteral administration of cefuroxime (2-4 g/day) for 4-16 days.
- Treatment targeted variously located acute infections in 120 drug addict outpatients.
- Monitoring for antibacterial activity and patient tolerability.
Main Results:
- Cefuroxime exhibited marked antibacterial activity against infections.
- The drug was well-tolerated by the patient group.
- Successful treatment outcomes were observed in the majority of cases.
Conclusions:
- Cefuroxime is an effective antibiotic for acute infections in immunocompromised outpatients.
- Excellent tolerability supports its use in this high-risk population.
- Cefuroxime is considered the antibiotic of choice for outpatient infections in immune-depressed subjects.